Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS). [electronic resource]
Producer: 20160707Description: 2097-101 p. digitalISSN:- 1569-8041
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Drug Administration Schedule
- Drug Combinations
- Follow-Up Studies
- Humans
- Lymphatic Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Oxonic Acid -- administration & dosage
- Prognosis
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Tegafur -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.